Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

Transfusion

Volumn 51, Issue 3, 2011, Pages 591-599

  Schmitt, Anita ^a   Tonn, Torsten ^a   Busch, Dirk H ^a   Grigoleit, Götz Ulrich ^a   Einsele, Hermann ^a   Odendahl, Marcus ^a   Germeroth, Lothar ^a   Ringhoffer, Mark ^a   Ringhoffer, Simone ^a   Wiesneth, Markus ^a   Greiner, Jochen ^a   Michel, Detlef ^a   Mertens, Thomas ^a   Rojewski, Markus ^a   Marx, Martin ^a   Von Harsdorf, Stephanie ^a   Döhner, Hartmut ^a   Seifried, Erhard ^a   Bunjes, Donald ^a   Schmitt, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTIVIRUS AGENT; ARABINOSIDE; CIDOFOVIR; FLUDARABINE; FOSCARNET; GANCICLOVIR; STEROID; T LYMPHOCYTE RECEPTOR; VALGANCICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOPTIVE TRANSFER; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; FEMALE; GOOD MANUFACTURING PRACTICE; GRAFT VERSUS HOST REACTION; HUMAN; POLYMERASE CHAIN REACTION; STEROID THERAPY; VIRAL CLEARANCE; VIRUS REACTIVATION;

ADOPTIVE TRANSFER; ADULT; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHOSPHOPROTEINS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSPLANTATION, HOMOLOGOUS; VIRAL MATRIX PROTEINS;

EID: 79952470341     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02940.x     Document Type: Article

References (22)

1. Broers AE, Van Der Holt R, Van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V, Löwenberg B, Cornelissen JJ. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000;95:2240-5. (Pubitemid 30167720)
2. Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:293-9. (Pubitemid 46322636)
3. Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 2003;102:4255-60. (Pubitemid 37494081)
4. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991;324:1005-11.
5. Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF, Buhles WC, DeArmond B, Meyers JD. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991;325:1601-7.
6. Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, Norman D, Mendez R, Keating MR, Coggon GL, Crisp A, Lee IC. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International valacyclovir cytomegalovirus prophylaxis transplantation study group. N Engl J Med 1999;340:1462-70. (Pubitemid 29220545)
7. Haerter G, Manfras BJ, de Jong-Hesse Y, Wilts H, Mertens T, Kern P, Schmitt M. Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis 2004;39:88-94.
8. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG. The human cytotoxic T lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor of pp65-specific CTL. J Virol 1996;70:7569-79. (Pubitemid 26340108)
9. Grigoleit GU, Kapp M, Hebart H, Fick K, Beck R, Jahn G, Einsele H. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)- specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor. J Infect Dis 2007;196:699-704. (Pubitemid 47293851)
10. Knabel M, Franz TJ, Schiemann M, Wulf A, Villmow B, Schmidt B, Bernhard H, Wagner H, Busch DH. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat Med 2002;8:631-7. (Pubitemid 34633443)
11. Neudorfer J, Schmidt B, Huster KM, Anderl F, Schiemann M, Holzapfel G, Schmidt T, Germeroth L, Wagner H, Peschel C, Busch DH, Bernhard H. Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens. J Immunol Methods 2007;20:119-31. (Pubitemid 46349106)
12. Yao J, Bechter C, Wiesneth M, Härter G, Götz M, Germeroth L, Guillaume P et al. Multimers staining of CMVpp65 specific T cells for diagnosis and therapeutic purpose - a comparative study. Clin Infect Dis 2008;46:96-105.
13. Schmitt M, Schmitt A, Rojewski M, Chen J, Götz M, Heyduk M, Giannopoulos K et al. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma elicits immunological and clinical responses. Blood 2008;111:1357-65. (Pubitemid 351213422)
14. Koehl U, Beck O, Esser R, Seifried E, Klingebiel T, Schwabe D, Seidl C. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia 2003;17:232-6. (Pubitemid 36175913)
15. Poulin JF, Sylvestre M, Champagne P, Dion ML, Kettaf N, Dumont A, Lainesse M, Fontaine P, Roy DC, Perreault C, Sékaly RP, Cheynier R. Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood 2003;102:4600-7. (Pubitemid 37494130)
16. Lacey SF, Villacres MC, La Rosa C, Wang Z, Longmate J, Martinez J, Brewer JC, Mekhoubad S, Maas R, Leedom JM, Forman SJ, Zaia JA, Diamond DJ. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. Hum Immunol 2003;64:440-52. (Pubitemid 36373774)
17. Cwynarski K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J, Goldman J, Craddock C, Moss PA. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001;97:1232-40. (Pubitemid 32183744)
18. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994;330:1185-91. (Pubitemid 24121987)
19. Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, Löffler J et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002;99:3916-22. (Pubitemid 35332029)
20. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333:1038-44.
21. Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, Osman H, Assenmacher M, Billingham L, Steward C, Crawley C, Olavarria E, Goldman J, Chakraverty R, Mahendra P, Craddock C, Moss PA. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005;202:379-86. (Pubitemid 41126955)
22. Wloch MK, Smith LR, Boutsaboualoy S, Reyes L, Han C, Kehler J, Smith HD, Selk L, Nakamura R, Brown JM, Marbury T, Wald A, Rolland A, Kaslow D, Evans T, Boeckh M. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis 2008;197:1634-42. (Pubitemid 351919626)